Earnings Per Share, Diluted of Lexaria Bioscience Corp. from 31 Jul 2010 to 30 Nov 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Summary
Lexaria Bioscience Corp. quarterly and annual Earnings Per Share, Diluted in USD/shares history and change rate from 31 Jul 2010 to 30 Nov 2025.
  • Lexaria Bioscience Corp. Earnings Per Share, Diluted for the quarter ending 30 Nov 2025 was -0.07, a 56% increase year-over-year.
  • Lexaria Bioscience Corp. Earnings Per Share, Diluted for the twelve months ending 30 Nov 2025 was -0.57, a 14% decline year-over-year.
  • Lexaria Bioscience Corp. annual Earnings Per Share, Diluted for 2025 was -0.66, a 40% decline from 2024.
  • Lexaria Bioscience Corp. annual Earnings Per Share, Diluted for 2024 was -0.47, a 53% increase from 2023.
  • Lexaria Bioscience Corp. annual Earnings Per Share, Diluted for 2023 was -1.01.
Source SEC data
View on sec.gov
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Change (%)
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Change (%)

Lexaria Bioscience Corp. Quarterly Earnings Per Share, Diluted (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 -0.57 -0.07 +0.09 +56% 01 Sep 2025 30 Nov 2025 10-Q 13 Jan 2026 2026 Q1
Q3 2025 -0.66 -0.14 +0.01 +6.7% 01 Jun 2025 31 Aug 2025 10-K 28 Nov 2025 2025 FY
Q2 2025 -0.67 -0.21 -0.08 -62% 01 Mar 2025 31 May 2025 10-Q 14 Jul 2025 2025 Q3
Q1 2025 -0.59 -0.15 -0.09 -150% 01 Dec 2024 28 Feb 2025 10-Q 14 Apr 2025 2025 Q2
Q4 2024 -0.5 -0.16 -0.03 -23% 01 Sep 2024 30 Nov 2024 10-Q 13 Jan 2026 2026 Q1
Q3 2024 -0.47 -0.15 01 Jun 2024 31 Aug 2024 10-K 28 Nov 2025 2025 FY
Q2 2024 -0.13 01 Mar 2024 31 May 2024 10-Q 14 Jul 2025 2025 Q3
Q1 2024 -0.06 01 Dec 2023 29 Feb 2024 10-Q 14 Apr 2025 2025 Q2
Q4 2023 -0.13 01 Sep 2023 30 Nov 2023 10-Q 10 Jan 2025 2025 Q1
Q2 2012 -0.02 0 +0.02 01 May 2012 31 Jul 2012 10-Q 12 Sep 2012 2012 Q3
Q1 2012 -0.04 -0.01 0 0% 01 Feb 2012 30 Apr 2012 10-Q 07 Jun 2012 2012 Q2
Q4 2011 -0.04 -0.01 0 0% 01 Nov 2011 31 Jan 2012 10-Q 13 Mar 2012 2012 Q1
Q3 2011 -0.04 0 01 Aug 2011 31 Oct 2011 10-K 30 Jan 2012 2011 FY
Q2 2011 -0.02 -0.02 01 May 2011 31 Jul 2011 10-Q 12 Sep 2012 2012 Q3
Q1 2011 -0.01 01 Feb 2011 30 Apr 2011 10-Q 07 Jun 2012 2012 Q2
Q4 2010 -0.01 01 Nov 2010 31 Jan 2011 10-Q 13 Mar 2012 2012 Q1
Q2 2010 0 01 May 2010 31 Jul 2010 10-Q 14 Sep 2011 2011 Q3

Lexaria Bioscience Corp. Annual Earnings Per Share, Diluted (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 -0.66 -0.19 -40% 01 Sep 2024 31 Aug 2025 10-K 28 Nov 2025 2025 FY
2024 -0.47 +0.54 +53% 01 Sep 2023 31 Aug 2024 10-K 28 Nov 2025 2025 FY
2023 -1.01 01 Sep 2022 31 Aug 2023 10-K 26 Nov 2024 2024 FY
2011 -0.04 0 0% 01 Nov 2010 31 Oct 2011 10-K 30 Jan 2012 2011 FY
2010 -0.04 01 Nov 2009 31 Oct 2010 10-K 30 Jan 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.